Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Amyloidosis and renal failure].

S Musini, G M Savazzi

    Recenti Progressi in Medicina
    |December 11, 1999
    PubMed
    Summary

    Amyloidosis involves abnormal protein deposits in tissues, often affecting kidneys. New diagnostic tools and therapies aim to manage this progressive condition by targeting precursor proteins.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Brain atrophy in uremia. Research of the causes and future perspectives.

    Nephron·2002
    Same author

    Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis.

    Nephron·2001
    Same author

    [Antiphospholipid antibody syndrome].

    Recenti progressi in medicina·2001
    Same author

    Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients.

    Nephron·1999
    Same author

    [Treatment of arterial hypertension in diabetic nephropathy. Certainties and hypotheses].

    Presse medicale (Paris, France : 1983)·1996
    Same author

    [The feasibility and current limits in the prevention of diabetic nephropathy].

    Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·1996

    Area of Science:

    • Nephrology
    • Pathology
    • Biochemistry

    Background:

    • Amyloidosis is a diverse group of disorders characterized by abnormal extracellular deposition of fibrillar proteins.
    • Renal involvement in amyloidosis can be primary or secondary to systemic disease.
    • Diagnosis traditionally requires tissue biopsy to confirm amyloid deposits.

    Discussion:

    • Novel diagnostic approaches include radiolabeled serum amyloid P component and monitoring urinary glycosaminoglycans.
    • Beta-2 microglobulin amyloid deposits are common in patients on long-term dialysis, causing osteoarticular issues and carpal tunnel syndrome.
    • Current treatments focus on reducing amyloid precursor proteins and improving survival, as no cure specifically resolves existing deposits.

    Key Insights:

    • Early detection and understanding of amyloid deposition mechanisms are crucial.
    • Dialysis-related amyloidosis presents unique clinical and pathological features.
    • Therapeutic strategies are evolving to manage precursor protein production.

    Outlook:

    • Future diagnostics may offer less invasive methods for amyloidosis detection.
    • Research into targeted therapies to clear amyloid deposits holds promise.
    • Improved management strategies aim to enhance quality of life and prognosis for affected patients.

    Related Experiment Videos